"Oxytocics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)
| Descriptor ID |
D010120
|
| MeSH Number(s) |
D27.505.696.875.737 D27.505.954.705.737
|
| Concept/Terms |
Oxytocics- Oxytocics
- Oxytocic Drugs
- Drugs, Oxytocic
- Uterine Stimulants
- Stimulants, Uterine
- Oxytocic Agents
- Agents, Oxytocic
Oxytocic Effect- Oxytocic Effect
- Effect, Oxytocic
- Oxytocic Effects
- Effects, Oxytocic
|
Below are MeSH descriptors whose meaning is more general than "Oxytocics".
Below are MeSH descriptors whose meaning is more specific than "Oxytocics".
This graph shows the total number of publications written about "Oxytocics" by people in this website by year, and whether "Oxytocics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 8 | 0 | 8 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 4 | 0 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 0 | 1 |
| 2023 | 3 | 1 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oxytocics" by people in Profiles.
-
A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial. Nat Med. 2024 Aug; 30(8):2343-2348.
-
Implementing E-MOTIVE for detection and treatment of postpartum haemorrhage in South Africa. S Afr Med J. 2023 Dec 04; 113(12):24.
-
Preliminary efficacy, feasibility and safety of intra-umbilical oxytocin to reduce the time to placental delivery at caesarean section: an exploratory randomized trial. Afr Health Sci. 2023 Sep; 23(3):1-7.
-
Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2024 03; 230(3S):S1046-S1060.e1.
-
Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage. N Engl J Med. 2023 Jul 06; 389(1):11-21.
-
Duration of third stage labour and postpartum blood loss: a secondary analysis of the WHO CHAMPION trial data. Reprod Health. 2021 Nov 14; 18(1):230.
-
Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020 11 24; 11:CD012754.
-
Balloon labour induction and the price of elegance. BJOG. 2020 12; 127(13):1655.
-
Maternal characteristics and causes associated with refractory postpartum haemorrhage after vaginal birth: a secondary analysis of the WHO CHAMPION trial data. BJOG. 2020 Apr; 127(5):628-634.
-
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018 12 19; 12:CD011689.